Market Overview

UPDATE: Bank Of America Reiterates On Universal Health Services On Impressive Beat And Raise

Share:
Related UHS
Credit Suisse On Managed Care: Starts Centene, UnitedHealth And Others At Outperform, WellCare At Underperform
Credit Suisse Initiates Coverage On Health Care Facilities: HCA, Lifepoint At Outperform, Tenet, Universal Health At Neutral
Westport Trims Nearly 39% of Stakes in Portfolio (GuruFocus)

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Universal Health Services (NYSE: UHS), and raised the price target from $106.00 to $113.00.

In the report, Bank of America noted, “EPS of $1.51 beat consensus/our est by $0.26 / $0.16 with $0.09 coming from additional TX reimbursement ($0.06 related to prior period). All Acute segment metrics were impressive and while UHS did not quantify the Reform benefit in the quarter or update the full year Reform outlook, the results suggest that Reform benefits accelerated and the core business was strong as well. UHS raised 2014 EPS guidance by $0.75 to $5.55-5.85.

"After adjusting for the additional TX revs and the Q1 beat, it appears the $0.17 Q2 beat (ex. TX item) is flowing through to 2H14 (2H outlook raised by $0.31). On top of the strong results, UHS doubled its dividend and announced a new share repo (up from prior) indicating a more aggressive deployment of capital. UHS's strong quarters on the heels of HCA's positive preannouncement is another positive sign for the group broadly and strong pysch results are a good data point of ACHC. We are raising our 2014/15/16E EPS to $5.85/$6.39/$6.57 from $5.23/$6.04/$6.27 and raising our PO to $113 from $106.”

Universal Health Services closed on Thursday at $97.54.

Latest Ratings for UHS

DateFirmActionFromTo
Feb 2016Standpoint ResearchUpgradesHoldBuy
Dec 2015Credit SuisseInitiates Coverage onNeutral
Oct 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for UHS
View the Latest Analyst Ratings

Posted-In: Bank of America Kevin FischbeckAnalyst Color Price Target Analyst Ratings

 

Related Articles (UHS)

View Comments and Join the Discussion!

Get Benzinga's Newsletters